Summary
ANGO has broken below a key support level at $12.64, currently trading at $10.98 (13.1% beyond the level). This technical breakout signals selling pressure and suggests potential downward pressure. The RSI at 30.3 suggests weak momentum. This is a 20-day trendline break.
Technical Chart
Breakout Analysis
When a stock breaks through an established support level with conviction, it often signals that the previous price barrier has been overcome. The 13.1% move beyond the support level indicates significant selling pressure.
Key Levels to Watch
| Breakout Level | $12.64 |
| Current Price | $10.98 |
| Break Distance | 13.1% |
Investment Advisor Score
50.0/100
HOLDOur AI-powered investment scoring system analyzes multiple factors including fundamentals, technicals, and market sentiment to generate this score.
Company Overview
AngioDynamics, Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Why This Matters
This technical breakout in ANGO suggests that institutional investors are repositioning based on their analysis of the company's prospects. When stocks break through established technical levels, it often indicates a shift in market sentiment that can drive sustained price movement.
The breakdown is particularly concerning given ANGO's thin -10.7% margins. Companies with limited profitability have less buffer against headwinds, potentially amplifying downside moves.
Competitive Position & Moat
AngioDynamics, Inc. possesses several key competitive advantages that bolster its market position. The company’s robust portfolio of patented medical devices, particularly in the fields of peripheral vascular disease and oncology, provides a significant barrier to entry for competitors. Their established brand reputation in the Med Tech and Med Device sectors enhances customer loyalty, while the specialized nature of their products creates high switching costs for healthcare providers who have already invested in AngioDynamics’ technologies. In terms of market position, AngioDynamics primarily serves the U.S. market, positioning itself as a trusted provider of innovative solutions such as its BioSentry and VenaCure products. These offerings differentiate the company by addressing critical healthcare needs with effective, minimally invasive treatments. The emphasis on quality and innovation further solidifies its standing against competitors in the medical device sector. However, AngioDynamics faces potential risks and competitive threats, particularly from larger players with greater economies of scale and extensive distribution networks. Additionally, advancements in technology may lead to new entrants or alternative treatment options that could disrupt the current market dynamics, necessitating continuous innovation and adaptation by AngioDynamics to maintain its competitive edge.Financial Health (SEC Data)
Based on the latest SEC filings, here's an analysis of ANGO's financial position:
Profitability Analysis
| Revenue | $300.72M |
| Net Income | $-32.09M |
| Profit Margin | -10.7% |
The company is currently unprofitable with a -10.7% margin. This may reflect growth investments or operational challenges.
Options Market Insight
| Options Confidence | 60.4/100 |
| Signal | Buy Calls |
| Recommendation | SPECULATIVE |
Speculative setup. Some confirming signals but also red flags. Size accordingly.
Options Flow Factors:
- Early entry - good timing
- Strong signal alignment (6/6)
Risk Factors:
- No identified catalyst - why is it moving?
- Low institutional flow - mostly retail
Technical Indicators
| RSI (14) | 30.3 |
| MACD Signal | Bearish |
| 50-Day SMA | $12.62 |
| 200-Day SMA | $12.47 |
| Price vs MAs | Below both (Bearish) |
Next Levels to Watch
| 20-Day Support | $10.60 |
| 100-Day Support | $8.93 |
| 50-Day SMA | $12.62 |
| 200-Day SMA | $12.47 |
Price has already broken below the 200-day SMA at $12.47, which is a bearish signal suggesting the longer-term trend may be turning down. Price is below the 50-day SMA at $12.62, confirming short-term bearish momentum. The 20-day support at $10.60 (3.6% below) is the next downside target if selling continues.
How to Trade This
| Entry Zone | $12.58 |
| Stop Loss | $12.89 |
| Target 1 | $10.60 |
| Target 2 | $10.28 |
Risk/Reward: Short entry at $12.58 with stop at $12.89 risks 2.5% for potential 15.7% gain (RR: 6.3:1).
Trading Considerations
- Confirmation: Watch for sustained price action below $12.64
- Volume: Look for volume confirmation on continued moves
- Role Reversal: Broken level at $12.64 may now act as resistance
- Risk Management: Always use stop-loss orders
Conclusion
ANGO's break below the $12.64 support level represents a significant technical development. Traders should monitor price action and volume for confirmation of this bearish signal.
Related Analysis for ANGO
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Past performance does not guarantee future results. Always do your own research and consider your risk tolerance before making trading decisions.